Merck and Sinopharm to Set Up Vaccine JV

Merck Sharp & Dohme (MSD), the international arm of US big pharma Merck, signed a letter of mutual intent with Sinopharm (China National Pharmaceutical Group Corporation) to cooperate on a vaccine for human papillomavirus (HPV). HPV, if left untreated, can cause cervical cancer. The two companies plan to establish a joint venture. More details.... Stock Symbols: (NYSE: MRK) (SHEX: 600511)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.